Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

esterified estrogens

esterified estrogens
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Menest TABLET, ORAL 0.3 mg, 0.625 mg, 1.25 mg, 2.5 mg      
VIEW MORE Estrogens
CLASS
681604
Comments:

Backorder (as of June 2023): The 0.625 mg tablet is on long-term backorder. Automatically interchange to Premarin 0.625 mg for the duration of the backorder.

Menest permanently discontinued as of late-2025. Utilize Premarin as needed (Pending P&T Review/Update February 2026).

 

Reviewed: October 25, 2006

Last updated: Jan. 29, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved